DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ — According to MarketsandMarkets™, the CRISPR Market is projected to reach USD 6.12 billion by 2031 from USD 3.48 billion in 2026, at a CAGR of 12.0% during the forecast period.

Browse 388 market data Tables and 53 Figures spread through 319 Pages and in-depth TOC on “CRISPR Market – Global Forecast to 2031”

CRISPR Market Size & Forecast:

Market Size Available for Years: 2026–20312026 Market Size: USD 3.48 billion2031 Projected Market Size: USD 6.12 billionCAGR (2026–2031): 12.0%

CRISPR Market Trends & Insights:

North America accounted for the largest share, 49.7%, of the CRISPR market in 2025.By offering, products accounted for the largest share of 70.7% of the CRISPR market in 2025.By application, drug discovery & development accounted for the largest share of the CRISPR market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204

The CRISPR market is expanding as pharmaceutical and biotechnology companies and academic & research institutes increasingly adopt gene-editing technologies to support drug discovery, functional genomics, therapeutic development, and agricultural research. CRISPR tools are widely used for gene knockout, knock-in, target identification and validation, disease modeling, cell line development, and high-throughput screening. Rising demand for precise, efficient genome editing is accelerating adoption of CRISPR kits & enzymes, libraries, gRNA solutions, and specialized screening and validation services. In addition, ongoing advances in CRISPR-Cas systems, gRNA design and optimization, base editing, prime editing, and gene delivery technologies are improving editing specificity, efficiency, and workflow scalability. The growing development of CRISPR-based therapies and wider application of gene editing across research and commercial settings are further supporting market expansion.

By offering, the products segment held the largest share of the CRISPR market in 2025.

By offering, the CRISPR market is segmented into products and services. In 2025, products accounted for the largest market share. This is mainly due to recurring demand for CRISPR kits, enzymes, libraries, guide RNAs, and other research consumables across gene-editing workflows. Pharmaceutical and biotechnology companies, as well as academic and research institutes, use these products for gene knockout, gene activation, functional genomics, target validation, and drug discovery. The growing adoption of CRISPR-based screening and increasing gene editing research further support product consumption. Continued development of advanced Cas enzymes, optimized guide RNA solutions, and ready-to-use CRISPR kits also supports the segment’s leading position.

By product type, the CRISPR kits & enzymes segment held the largest share of the CRISPR product market in 2025.

By product type, the CRISPR product market is segmented into CRISPR kits & enzymes, CRISPR libraries, and other products. In 2025, CRISPR kits & enzymes accounted for the largest market share. Their leading position is supported by their extensive use across routine gene editing, target validation, cell engineering, and functional genomics workflows. CRISPR kits provide researchers with standardized components for gene knockout, knock-in, and other genome editing experiments, while enzymes such as Cas9 and other Cas nucleases are core components of CRISPR workflows. Their broad applicability across pharmaceutical research, biotechnology R&D, and academic laboratories creates recurring demand. The availability of workflow-specific kits and improved CRISPR enzymes with enhanced editing performance further supports this segment’s dominance.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134401204

By region, North America accounted for the largest share of the market in 2025.

In 2025, North America held the largest share of the CRISPR market. This is supported by strong biotechnology and pharmaceutical research activity, high investment in gene editing, and a well-established life sciences infrastructure. The US leads the region in CRISPR-based drug discovery, functional genomics, high-throughput screening, and therapeutic development. Leading CRISPR technology providers, biotechnology companies, academic research institutes, and pharmaceutical companies create strong demand for CRISPR products and services. Growing clinical development of gene-edited therapies and continued advancements in CRISPR-Cas systems, guide RNA technologies, and screening platforms further support market growth in North America.

Key Players

Leading players in the CRISPR companies include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134401204

CRISPR Market – Investment & funding +Merger & Acquisition

Investment Funding Context

The CRISPR market is seeing increasing investment and funding activity, driven by expanding gene-editing therapeutic pipelines, advances in CRISPR-Cas technologies, and the growing development of next-generation approaches such as base editing, prime editing, and epigenetic editing. Investment activity is increasingly focused on improving editing precision and delivery, advancing therapeutic candidates through clinical development, and expanding applications across genetic diseases and other therapeutic areas. For instance, in January 2025, Tune Therapeutics raised USD 175 million in Series B financing to advance its epigenetic editing platform and therapeutic pipeline. The financing highlights continued investor interest in differentiated gene-editing technologies with potential to address a broader range of diseases. This funding activity supports technology development, clinical translation, and commercialization across the CRISPR market.

Revenue Shift Context

The CRISPR market is gradually shifting revenue from conventional CRISPR-Cas9 systems and basic gene-editing reagents toward higher-growth categories such as engineered Cas nucleases, advanced CRISPR kits, high-throughput screening solutions, base editing, prime editing, and specialized gene-editing services. The global CRISPR market is projected to increase from USD 3.48 billion in 2026 to USD 6.12 billion by 2031, at a CAGR of 12.0%, with a growing share of incremental revenues expected from advanced editing platforms, customized gRNA solutions, CRISPR libraries, cell line development, and screening & validation services. Meanwhile, conventional Cas9-based products remain an important revenue base, but next-generation editing technologies and specialized services are gaining adoption across pharmaceutical & biotechnology companies and academic & research institutes.

Mergers and Acquisitions

Mergers and acquisitions in the CRISPR market are being driven by the need to strengthen gene-editing technology portfolios, gain access to proprietary CRISPR platforms, expand therapeutic development capabilities, and acquire expertise in next-generation editing and delivery technologies. Such transactions also enable companies to broaden their presence across drug discovery, functional genomics, and CRISPR-based therapeutic development.

CRISPR MARKET: MERGERS AND ACQUISITIONS, JANUARY 2023–SEPTEMBER 2026

Company Revenue Share Details

The top four players collectively account for approximately 25-27% of the global CRISPR market, indicating a highly competitive landscape. This reflects established life sciences companies alongside specialized gene-editing technology and service providers. Key market participants include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunvBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), and Lonza (Switzerland). These companies compete across CRISPR kits & enzymes, libraries, gRNA solutions, cell line development, screening & validation, and other gene-editing services. Continued innovation in advanced CRISPR systems, editing optimization, high-throughput screening, and specialized services is further intensifying competition across the market.

Browse Adjacent Market: Biotechnology Market Research Reports &Consulting

See More Latest Medical Devices Reports:

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) – Global Forecast to 2029

Genomics Market Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) – Global Forecast to 2030

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/crispr-technology-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/crispr-technology.asp

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/crispr-market-worth-6-12-billion-by-2031—exclusive-report-by-marketsandmarkets-302911142.html

New locations complement the credit union’s nationwide digital capabilities while strengthening member relationships and community connection

HAUPPAUGE, N.Y., Oct. 16, 2026 /PRNewswire/ — Teachers Federal Credit Union, one of the nation’s largest credit unions with $9.9 billion in assets and over 472,000 members, is continuing to expand its branch network across New York and Florida, with new locations planned for Estero and Wesley Chapel, Florida, and Farmingville, New York.

With a national open charter and members across all 50 states, Teachers combines the convenience of digital banking with access to personalized financial guidance. As the credit union’s membership has grown nationwide, its physical footprint has evolved alongside it, with continued investment in its home state of New York and an increasing presence in Florida. Teachers is also identifying additional markets across the country where a branch can bring the credit union closer to its members and support its long-term mission of helping members build a strong financial foundation today, for a better tomorrow.

“Our growth is guided by how we can better serve our members and support their financial well-being,” said Brad Calhoun, President and CEO of Teachers Federal Credit Union. “Our digital capabilities make it possible for us to serve members wherever they are, while our branches provide opportunities to build personal relationships and offer guidance through the financial moments that matter most. As we continue to expand in New York, strengthen our presence in Florida, and enter new markets, we remain focused on giving members more convenient ways to connect with Teachers and access the personalized service, expertise, and support they value – wherever and whenever they need us.”

To help guide its branch strategy, Teachers partnered with global commercial real estate services firm JLL to conduct a market screening.

“Establishing our partnership with JLL was an important step in developing our approach to branch expansion. We wanted to understand where our members are, what markets are evolving, and where a physical presence could create the greatest opportunity for Teachers,” added Inna Sprague, Chief Experience Officer, Teachers Federal Credit Union. “We combined internal data with factors such as market growth, demographics, competition, and site characteristics of potential locations to develop a branch expansion strategy that aligned with member needs, market opportunity, and our broader growth goals.”

Teachers has steadily expanded its branch network in recent years, entering the Florida market with its first location in Tampa’s Westshore district in 2023 and building on that presence with branches in Naples in 2025 and Lake Mary, serving the greater Orlando region, in 2026. In New York, Teachers opened a new branch in Holbrook in 2025 and continues to invest in its Long Island footprint. The planned locations in Estero, Wesley Chapel, and Farmingville represent the next phase of that strategy, expanding access in markets where Teachers sees opportunities to serve both existing and future members.

As Teachers grows, its investment in the communities it serves grows with it. The credit union’s approach extends beyond opening branches to supporting organizations and causes that make a meaningful difference in the places where its members live and work. Through its annual Golf Tournament benefiting Children’s Miracle Network, Teachers has raised more than $3 million since 2023 to support children and families, including through partnerships with Cohen Children’s Medical Center in New York and Johns Hopkins All Children’s Hospital and Nicklaus Children’s Hospital in Florida. Teachers also supports the American Cancer Society through Making Strides Against Breast Cancer, serving in 2026 as Presenting Sponsor on Long Island and Eastern Long Island and Silver Sponsor in Tampa Bay and Southwest Florida.

For more information about Teachers Federal Credit Union, please visit www.teachersfcu.org

About Teachers Federal Credit Union
Teachers Federal Credit Union (Teachers) is one of the country’s largest credit unions, with $9.9 billion in assets and over 472,000 members across all 50 states. Founded in New York in 1952, Teachers is a full-service, not-for-profit financial institution with an open charter offering membership to anyone in the U.S. through its 33 full-service branches and best-in-class digital solutions. Teachers is a key supporter of the communities it serves and is proud to offer a range of member-focused products with competitive rates and low fees. What started as a smart solution for teachers is now smart for all. For more information, visit www.teachersfcu.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/teachers-federal-credit-union-accelerates-strategic-branch-expansion-across-new-york-and-florida-302911362.html

SOURCE Teachers Federal Credit Union

Novogradac to Host 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 in Washington, D.C.

SAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ — Clean energy professionals will gather to receive actionable, technical insights into navigating the evolving renewable energy tax credit (RETC) market at the Novogradac 2026 Fall Renewable Energy Tax Credits Conference, Nov. 5-6 at the Fairmont Washington, D.C. Georgetown.

Set at a pivotal moment for the renewable energy market and immediately after the 2026 mid-term elections, this conference will bring together attorneys, developers, investors, lenders, tax insurance providers and advisors to examine the policy, structuring and financing issues shaping RETC investments. Attendees will engage with practical, technically focused content regarding deal execution, market developments and the challenges industry professionals are facing.

Sessions at the conference will discuss recent federal developments affecting clean energy tax incentives, technical tax considerations shaping deal execution, the clean energy development landscape and how it is evolving, what is driving investor interest in certain properties, tax equity structures and more. The full conference agenda can be found here.

“This year, the RETC sector has been shaped by major changes in federal policy and guidance. It’s important to stay up to date with the current state of the market,” said Tony Grappone, a partner in Novogradac’s North Andover, Massachusetts, office and chair of the conference. “This conference offers a targeted experience centered on technical content and represents an opportunity to connect with other professionals facing similar challenges.”

The Novogradac 2026 Fall Renewable Energy Tax Credits Conference is co-hosted by Bildmore, CAC, Crux, Foley and Lardner, Monarch Private Capital, Nixon Peabody and Raymond James. Conference sponsors include Alliant, Alston & Bird, Aon, Concentro, Crowell & Moring, DLA Piper, Euclid Transactional, Foley Hoag, Foss & Company, Howden, Key State, Latham & Watkins, Lux Speed Capital, National Trust Energy Capital, Reunion, Ryan, Sugar Creek Capital and Summit Ridge Energy. Kutak Rock and Prince Lobel will be exhibitors at the conference.

Novogradac will host a pre-conference workshop Wednesday, Nov. 4. The Project Finance Primer: Fundamentals & Monetization workshop will provide insights into financing clean energy developments by using tax credits as part of the capital stack. Topics of discussion will include the state of the market, what incentives are available, various tax equity structures and hot topics such as foreign entities of concern, prevailing wage and apprenticeship, domestic content and more. Separate registration fees apply for the pre-conference workshop.

About Novogradac
Novogradac, which has been in business for more than 35 years, has grown to more than 800 employees and partners with offices in more than 25 cities. Tax, audit and consulting specialty practice areas for Novogradac include affordable housing, community development, historic rehabilitation and renewable energy. For additional information on Novogradac’s personnel and areas of expertise, visit www.novoco.com or call (415) 356-8000.

View original content:https://www.prnewswire.com/news-releases/renewable-energy-tax-credit-professionals-to-explore-changing-energy-policy-landscape-at-novogradac-conference-302910360.html

SOURCE Novogradac & Company LLP